ArticleInternational journal of molecular sciences2024

A Brazilian Rare-Disease Center's Experience with Glucosylsphingosine (lyso-Gb1) in Patients with Gaucher Disease: Exploring a Novel Correlation with IgG Levels in Plasma and a Biomarker Measurement in CSF.

Matheus Vernet Machado Bressan Wilke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.